Loading clinical trials...
Loading clinical trials...
The purpose of this study is to evaluate the safety and effectiveness of CyPass implantation as a stand-alone therapy for lowering intraocular pressure (IOP) in patients with primary open angle glauco...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Transcend Medical, Inc.
NCT06630546 · Primary Open Angle Glaucoma (POAG), Istent Inject W, and more
NCT02700984 · Primary Open Angle Glaucoma (POAG)
NCT01252849 · Primary Open Angle Glaucoma (POAG)
NCT01085357 · Primary Open Angle Glaucoma (POAG), Cataract
NCT00902109 · Primary Open Angle Glaucoma (POAG)
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions